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Abstract
Introduction: We report a pathfinder study of AI/knowledge engineering methods to
rapidly formalise COVID-19 guidelines into an executable model of decision making
and care pathways. The knowledge source for the study was material published by
BMJ Best Practice in March 2020.
Methods: The PROforma guideline modelling language and OpenClinical.net
authoring and publishing platform were used to create a data model for care of
COVID-19 patients together with executable models of rules, decisions and plans
that interpret patient data and give personalised care advice.
Results: PROforma and OpenClinical.net proved to be an effective combination for
rapidly creating the COVID-19 model; the Pathfinder 1 demonstrator is available for
assessment at https://www.openclinical.net/index.php?id=746.
Conclusions: This is believed to be the first use of AI/knowledge engineering
methods for disseminating best-practice in COVID-19 care. It demonstrates a novel
and promising approach to the rapid translation of clinical guidelines into point of
care services, and a foundation for rapid learning systems in many areas of
healthcare.
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1 | COVID-19 AND THE POLYPHONY
PROJECT
The COVID-19 emergency is a massive challenge to human expertise
and organisation, but it is also widely recognised as an opportunity to
demonstrate, test and improve medical technologies, including artifi-
cial intelligence (AI) techniques for delivering rapid learning systems.
Over recent years, we have been developing a flexible methodology
for creating executable models of specialist clinical expertise and a
platform for sharing these models called OpenClinical (www.
OpenClinical.net).1
OpenClinical is one of a number of efforts in recent years to use
knowledge engineering and other techniques to formalise clinical guide-
lines as “executable knowledge.”2,3 Although systematic reviews, clinical
guidelines, etc, have been important tools of the evidence-based medi-
cine movement their impact in improving consistency and quality of
care has been less than hoped for because they are disseminated purely
as human readable content (eg, text, diagrams) in a traditional, often
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slow, publication and revision cycle. OpenClinical has made use of one
particular approach to formalising clinical guidelines based on a spe-
cialised modelling language called PROforma4,5; we adopted this
approach because it has been used and trialled successfully in many
medical applications6 and we have wide experience using it.
We see OpenClinical as the basis of a rapid learning system as
illustrated in Figure 1. This shows a knowledge life cycle for creating
and maintaining executable models of care using the OpenClinical.net
knowledge modelling and publishing platform. The top arrow of the
cycle represents creation and testing of models using PROforma
authoring software; the next step on the right is to publish them on
the OpenClinical.net repository (which currently carries 50+ examples
of executable models for many clinical settings and specialties,
https://dev.openclinical.net/index.php?id=69).
This lifecycle overlaps with other Rapid Learning Systems (RLS)
proposals, notably Friedman et al's2 MCBK proposals but is distinctive in
using PROforma, a specialised AI language, for modelling and to support
open source sharing of models. Although PROforma has been successful
in these roles the goal of OpenClinical is primarily to provide a platform
for crowdsourcing, validating and disseminating models not to deliver
clinical services directly. A key aim of the OpenClinical project is to “close
the loop” (left arrow) by incorporating software for acquiring clinical data
from clinical implementations and trials of the models. This will permit
use of data mining, machine learning and other techniques to update the
evidence base and refine clinical guidelines and other care quality
standards.
The Polyphony project was initiated on 18 March 2020 with the
following mission.
To create, validate, publish and maintain knowledge of
best medical practice regarding the detection, diagno-
sis and management of COVID-19 infections, in a com-
puter executable form. The purpose is to provide a
resource for clinicians and researchers, healthcare pro-
vider organisations, technology developers and other
users, to (1) develop point of care products and
services which (2) embody best clinical practice in deci-
sion-making, workflow, data analysis and other “intelli-
gent” services across the COVID patient journey.
Among the questions we aimed to address in Polyphony are the
following which relate directly to the knowledge lifecycle in Figure 1:
• Can we create executable models of best practice in the care of
COVID-19 patients? Can this demonstrate and maintain a
standardised model of good practice (“reference model”)?
• How useful is the OpenClinical knowledge sharing framework for
empowering clinicians to critique and improve models of decision-
making and care across the patient journey?
• Is it possible to adapt components of the model for use in different
clinical settings or in local variants of care pathways?
• What is the potential for combining knowledge engineering
methods with techniques from data science (eg, statistical analysis,
data mining and machine learning)?
This article is a progress report on our first prototype, Pathfinder
1, and the design and engineering framework we have developed to
support the Polyphony mission. The online demonstrator is not com-
plete or “clinical strength” but this is the goal of future cycles of Fig-
ure 1.* However sufficient progress has been made that it may be of
interest to the RLS community.
2 | METHODS
2.1 | PROforma
The PROforma language is based on a general framework for model-
ling tasks, including reasoning, decision-making and planning. Task
models can be applied to knowledge about a particular medical
domain such as the diagnosis and treatment of COVID-19 patients,
formalised in PROforma or available in external resources.
F IGURE 1 The
OpenClinical knowledge-to-
data cycle for rapid learning
systems
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The OpenClinical knowledge model is illustrated schematically in
Figure 2. At the bottom of the ladder are symbols (eg, “fever,” “38.6”)
which can be combined to represent data (eg, presenting symptoms
include fever) and concepts (eg, diagnosis is a kind of decision; path-
way is a kind of plan) and descriptions (eg, patient histories). PROforma
can be used to model knowledge as rules for inference or action.
Where inference is uncertain rules can participate in complex decisions
as a basis for constructing arguments for and against competing deci-
sion options. Finally, decisions, actions and enquiries (actions that
acquire information) can be composed into plans to achieve particular
objectives. In principle plans can be encapsulated as agents that can
carry out complex behaviour autonomously, though agent modelling
is not within the scope of the Polyphony programme.
2.2 | Knowledge modelling
PROforma can be used to model clinical guidelines of various types
including medical logic and recommendations, decision trees, clinical
algorithms, etc. Early development of the COVID-19 knowledge base
in Pathfinder 1 relied primarily on documentation published by BMJ
Best Practice in March 2020.† The OpenClinical modelling and testing
platform was used by an experienced PROforma modeller advised by
clinicians with specialist knowledge in public health and primary care.
In Pathfinder 1 the concepts and components of the BMJ Best prac-
tice guidance were mapped directly to levels of the knowledge ladder.
The resulting COVID-19 model consists of five main sections: the data
model; clinical contexts (data sets and scenarios); rules (inference and
alerts); decisions (arguments and evidence); and care pathways. In the
following paragraphs, we summarise how these are modelled in the
various modules of Pathfinder 1. A module overview can also be seen
in the graphic on the Pathfinder page on OpenClinical.
2.3 | Data model
The OpenClinical platform includes a tool to create data definitions for
relevant clinical and other parameters, their types (strings, integers,
date-times, etc) and other properties.‡ The full model for Pathfinder 1
consists of 46 data definitions based on the BMJ Best Practice docu-
mentation (March 2020). These are at the symbol level of the knowl-
edge ladder in Figure 2.
2.4 | Clinical contexts
A clinical context is typically a scenario on the patient journey in
which one or more decisions may be taken and for which subsets of
the data model are relevant. One scenario is “patient triage” where a
handful of questions may be asked relevant to a decision whether to
do nothing, advise self-isolation or book an ambulance. Another con-
text is “hospital work-up” which covers a detailed patient history to
inform a provisional diagnosis and initial selection of investigations.
Based on the BMJ guidance 10 contexts were identified and mod-
elled. Pathfinder 1 emphasises pre-hospital scenarios with less empha-
sis on hospital and acute care, though by the time of publication BMJ
Best Practice has added more guidance on the latter stages of the
journey.
2.5 | Rules: Inference and alerts
As shown in the knowledge ladder PROforma supports several knowl-
edge types, of which the simplest is the if…then… rule. Rules respond
to situations or events expressed in Boolean logic. For example, if a
patient's temperature is >38.6 Pathfinder infers there is a fever; when
hazardous situations are detected “red flags” are raised. Other uses of
rules are to alert the user if a task has not been carried out or is over-
due, or when a patient is eligible for inclusion in an open research
trial.7
2.6 | Decisions
A PROforma decision model consists of a set of options and a set of
“arguments” (pros and cons) associated with each option. If an argu-
ment expression is evaluated against current patient data or other
information and found to be valid, it is recorded as a reason for (or
against) the relevant option with an explanation and, if required,F IGURE 2 The PROforma knowledge ladder
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supporting evidence that justifies the argument. All options in an
active decision context accumulate patient-specific pros- and cons as
data are acquired, and the decision engine aggregates these to pro-
vide a continuously updated measure of confidence in each option. In
the initial modelling stage arguments are usually modelled qualita-
tively but if statistical or other data are available they can be assigned
quantitative weights which can be aggregated using various possible
decision algorithms.
Eight main decisions have been modelled for the COVID-19
patient journey, including triage, diagnosis, prognosis, prediction of
complications and choice of management plan. All decisions are con-
currently active in Pathfinder 1 but they can also be deployed at spe-
cific points or in particular scenarios in the care pathway.
2.7 | Pathways
A “pathway” is a network of decisions and tasks for acquiring data
and carrying out plans in a sequential and/or conditional way as
illustrated in Figure 3. In the first version there is an enquiry (green
diamond) about a small number of key data relevant to an initial
assessment (eg, presenting complaints, age of patient and whether
patient seems ill). If required a more detailed history is taken but
either way an escalation decision follows. A later version shown in
the second panel is based on more detailed guidance to GPs publi-
shed later by BMJ.
3 | RESULTS
Pathfinder 1 can be accessed via the link https://www.openclinical.
net/index.php?id=68, where there are instructions for running the
demonstrator against example cases provided or against the user's
own cases. Figure 4 shows three screenshots from a typical run
against example case 1.
When running the online demonstrator the following points
should be borne in mind: (a) The model is developed as a “standalone”
resource for testing and validation and is not intended to be deployed
F IGURE 3 Two versions of remote consultation pathways for GP scenarios
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directly into clinical use. The model is incomplete with respect to cur-
rent COVID-19 guidance which has evolved significantly since com-
pletion of the first modelling cycle; we expect to make significant
revisions to the data model and knowledge content in light of experi-
ence and feedback before starting on the next modelling cycle (Path-
finder 2).
F IGURE 4 Screenshots of data and
argumentation in the diagnosis decision, for
example, case 1. A, Loading one of the patient
test cases (ack. BMJ), B, a data entry form for
a GP consultation, partly pre-populated from
the case, and C, arguments for different
diagnoses based on presenting data
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4 | DISCUSSION
4.1 | Assessment against project objectives
4.1.1 | Creation of an executable model of best
practice for supporting care of COVID-19 patients
PROforma is capable of modelling the main decisions and workflows
across the COVID-19 patient journey. Pathfinder was developed in
about 3 weeks but is incomplete with respect to published medical
knowledge and recommended practice and the data, decision and
pathway models all require improvement and validation by qualified
clinicians. Our provisional assessment is that the model could be com-
pleted and maintained on a rapid timescale. A complementary path-
way for hospital care of COVID-19 patients has also been rapidly
developed in PROforma by Deontics Ltd.§ The focus of Pathfinder 2 is
on extending the pathways for additional clinical contexts (eg, comor-
bidity management).
4.1.2 | Appraisal of the OpenClinical platform as a
practical knowledge sharing infrastructure
Pathfinder 1 was deployed on OpenClinical.net as a globally accessi-
ble, open access demonstrator in early April 2020. A modified version
was made in response to comments and suggestions of the clinical
authors and made privately available for testing by them shortly after.
The incorporation of example test cases provided by clinical collabora-
tors and independent reviewers helps to quickly familiarise users with
the demonstration and to critique the decision models and pathways
against realistic patient data.
4.1.3 | Reusability of the data and knowledge
models at different points in the care journey
The “escalation decision” in the reference model was initially used in a
self-triage pathway and reused in the residential care triage pathway
of Pathfinder 1, but was replaced with three different decisions in the
GP consultation pathway in light of clinical comments and new publi-
shed guidance. In the latter pathway the diagnosis decision from the
Pathfinder 1 model was reused without change, but significant
changes were made to the initial assessment scenario and additional
decisions about diagnosis and appropriate actions were added to the
later pathway model.
4.1.4 | Scope for integrating data analysis and
machine learning functions
At this early stage of the project, we have not been able to progress
this question but are seeking to collaborate with data science special-
ists in the next cycle of the project. Initial discussions suggest,
however, that once case records for a population of patients are avail-
able it will be practical to exploit well established statistical and
machine learning methods to calibrate argument weights for patient
populations, for example, and there is also scope for symbolic machine
learning methods to suggest extensions to the logical knowledge
model (eg, rule induction methods).
4.2 | Deployments
As explained above the main goal of the Polyphony project is to
develop a “reference” data and knowledge model, not to deploy the
model directly but to be a resource for others to use in developing
clinical services. This is in part due to the complexities of integrating
decision support and other services with existing IT infrastructure. As
mentioned above Deontics Ltd. have developed a decision support
application for hospital patient assessment and deployed it in the
emergency department of the Liverpool and Broadgreen University
Hospital. Integration with the hospital EMR and infrastructure has
been achieved but was significantly more complex than the PROforma
modelling step.
Readers interested in deployment of services will ask how
PROforma engages with relevant technical standards, such as medical
coding and terminology standards (eg, ICD10; LOINC), ontologies (eg,
SNOMED CT, UML), logical expressions (eg, GELLO) and rules (eg,
Arden Syntax; CQL). PROforma overlaps conceptually but does not
comply with these standards. The emphasis in PROforma is on captur-
ing knowledge of these and other kinds in a single language for which
it offers a unified syntax and execution semantics.4 This is highly pref-
erable to modelling a complex body of knowledge with ad hoc combi-
nations of notations.8
The development of HL7 FHIR resources has a similar motivation
and we are interested in exploring whether PROforma can implement
certain classes of FHIR resources, such as the FHIR plan definition
(https://www.hl7.org/fhir/plandefinition.html) and FHIR executable
knowledge artifact (https://www.hl7.org/fhir/clinicalreasoning-
knowledge-artifact-representation.html). We think that this may make
integration and deployment easier without losing the simplicity and
intuitiveness of the PROforma and Polyphony framework.
If the Polyphony model is to have a sustainable future it will need
to be repeatedly updated as knowledge of COVID-19 and current
clinical practice change. Maintenance can take place at two levels, the
implementation (eg, software) level and the practice (knowledge)
level.
We anticipate that the maintenance of the implementation can
be managed through standard software engineering and version con-
trol methods. This allows messages and documentation outlining the
rationale for the change to be associated with each iteration of the
implementation. Present version control tools also keep a history of
all changes, including highlighting differences between versions for
easy review/audit. Classical version control would, for example, be
appropriate at the level of HL7 resources and their mappings to the
knowledge model.
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Maintenance at the knowledge level is likely to be very different
because the principle stakeholders here are professional clinicians,
researchers and other subject matter experts. Polyphony was
established under the auspices of the OpenClinical knowledge sharing
project which seeks to establish a framework for knowledge dissemi-
nation analogous to open access publishing. Key here are the need for
models to be intuitive and open to review and criticism by profes-
sional who have little expertise or interest in technicalities. New ver-
sions of knowledge models need to specify their provenance, the
evidence on which changes are based and in clinical use any unex-
pected behaviour must be explainable in appropriate medical terms.
4.3 | Wider questions
If COVID-19 remains clinically challenging in the medium-term it
would be desirable to recruit experienced healthcare professionals to
contribute to modelling the knowledge underlying decisions and path-
ways. Through OpenClinical we hope to support a sustainable com-
munity of practice to promote discussion and debate and to own and
maintain the reference knowledge base. A possible organisational
structure could be analogous to the “chromosome committees” of the
human genome project in that specialist professional groups of GPs,
emergency medicine clinicians, etc. would take responsibility for data
and knowledge modelling in specific contexts along the patient jour-
ney, but adopting common data and knowledge representation
standards.
In the longer term, with the hoped-for arrival of an effective vac-
cine or treatments, the COVID-19 emergency may pass or become
tolerated as a seasonal burden like flu. These futures are controversial,
and we take no position on them, but it is widely accepted that the
COVID-19 pandemic is only the latest in a series of infections with
major consequences for human populations and there will be more to
come. It will be important to have “rapid response” as well as “rapid
learning” mechanisms in place. Polyphony may help to inform the
design of policies and mechanisms by which expert and experienced
healthcare professionals can form rapid response teams to address
emerging threats.
A longer-term objective is based on the proposition that the
Polyphony approach is not limited to the COVID-19 emergency nor
even only to infections. The methods outlined here are applicable to
rapid deployment of executable clinical guidelines and quality stan-
dards generally. We believe they can be used to create open access
and open source models of practice for many conditions whether
acute or chronic, commonplace or rare, “from home to hospital
to home”.
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ENDNOTES
*As medical knowledge is constantly advancing there will never be a com-
plete model. This is particularly clear in the case of COVID-19 where the
pace of advance and changes in practise are so extraordinarily rapid.
†Thanks to Kieran Walsh and Chris Wroe at BMJ Best practice for permis-
sion to use the BMJBP article on COVID-19 as the source material for this
project (https://bestpractice.bmj.com/topics/en-gb/3000168). The con-
tent has been continuously updated by BMJ since then.
‡There are a number of commercial PROforma authoring tools available
including Arezzo (Elsevier) and Alium Composer (Deontics).
§Declaration of interest: Deontics Ltd. is a spinout from the University of
Oxford, University College London and Cancer Research UK. J. F. is a
founder and holds equity in the company.
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